The current valuation score of Arvinas Inc is 6.66, ranking 301 out of 384 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.58, which is -15.09% below the recent high of -2.19 and -560.30% above the recent low of -17.05.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.